Press – Maiwald

Press Coverage

11 Mar 2025 - Press Coverage

Roche gets Illumina unit’s DNA testing patent revoked

Roche has successfully persuaded a European appeals panel to revoke a patent held by Illumina’s subsidiary, Verinata Health, for detecting fetal DNA in maternal blood. The European Patent Office (EPO) ruled that the patent lacked an inventive step, as a prior application f...

12 Feb 2025 - Press Coverage

Royalty Pharma Announces $250M R&D Funding Collaboration with Biogen

New York, NY, February 12, 2025 – Royalty Pharma (Nasdaq: RPRX) has entered into an agreement with Biogen to provide up to $250 million in research and development (R&D) funding for litifilimab, a first-in-class investigational biologic in Phase 3 tria...

28 Nov 2024 - Press Coverage

Swerving the matter of granting genetic scissor patents at the EPO

The European Patent Office (EPO) was expected to issue key rulings on CRISPR/Cas9 patents this autumn, but instead, legal uncertainty persists. Nobel Prize winners Emmanuelle Charpentier and Jennifer Doudna, pioneers of the technology, withdrew their patent applications befo...

All press coverage

Maiwald press releases

25 Mar 2025 - Press Release

Roche gets Illumina unit’s DNA testing patent revoked

A European Patent Office board of appeal said in a ruling published on March 10th that Roche Diagnostics GmbH proved Verinata Health Inc.'s blueprint lacks an inventive step over an earlier international patent application setting out a similar way of testing "free-floating ...

20 Dec 2022 - Press Release

Maiwald wins important opposition case for its client Acetate International LLC at the European Patent Office

Maiwald GmbH in Munich has achieved an important victory for its client Acetate International LLC at the European Patent Office. Acetate International LLC is part of the Celanese group which has a long history of producing cellulose acetate products for commercial applicatio...

11 Oct 2022 - Press Release

Law firm will in future operate as Maiwald GmbH

Munich, 11 October 2022 - Maiwald, one of Germany's largest and most renowned law firms in the field of intellectual property, will in future operate under a new name: Effective October 11, 2022, Maiwald Patentanwaltsgesellschaft und Rechtsanwaltsgesellschaft mbH changed its...

All press releases

Maiwald in the press

Press Coverage

Roche gets Illumina unit’s DNA testing patent revoked

Royalty Pharma Announces $250M R&D Funding Collaboration with Biogen

Swerving the matter of granting genetic scissor patents at the EPO

Maiwald press releases

Roche gets Illumina unit’s DNA testing patent revoked

Maiwald wins important opposition case for its client Acetate International LLC at the European Patent Office

Law firm will in future operate as Maiwald GmbH

Press Contact

Dr. Eva Dörner